Carnegie Investment Counsel’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
39,215
+830
+2% +$38.1K 0.04% 254
2026
Q1
$1.57M Buy
38,385
+535
+1% +$22.9K 0.03% 278
2025
Q4
$1.62M Sell
37,850
-320
-0.8% -$13.6K 0.03% 279
2025
Q3
$1.6M Buy
38,170
+90
+0.2% +$3.63K 0.03% 271
2025
Q2
$1.48M Buy
+38,080
New +$1.37M 0.03% 271

Other funds holding TSPA

Carnegie Investment Counsel's TSPA Position: Q2 2026 in Review

Carnegie Investment Counsel increased its T. Rowe Price US Equity Research ETF (TSPA) stake by 2.2% in Q2 2026, buying an estimated $38.1K and bringing the position to 39,215 shares worth $1.86M. The position accounts for 0.04% of the portfolio, ranked #254.

Carnegie Investment Counsel first reported a position in TSPA in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold TSPA as of Q2 2026.

  • Carnegie Investment Counsel held 39,215 shares of T. Rowe Price US Equity Research ETF worth $1.86M as of Q2 2026.
  • Carnegie Investment Counsel bought 830 T. Rowe Price US Equity Research ETF shares in Q2 2026, an estimated $38.1K.
  • T. Rowe Price US Equity Research ETF made up 0.04% of Carnegie Investment Counsel's portfolio in Q2 2026, its #254 holding.
  • Carnegie Investment Counsel first reported a position in T. Rowe Price US Equity Research ETF in Q2 2025 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.